05/13/2024
7:01 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
7:05 AM | UroGen Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
1:22 PM | BlackRock Inc. (Filed by)
UroGen Pharma (Subject)
| Form SC 13G/A | |
04/29/2024
7:18 AM | UroGen Pharma (Filer)
| Form 10-K/A | |
03/20/2024
3:38 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
12:48 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
7:16 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/14/2024
7:17 AM | UroGen Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
6:00 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
6:00 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
8:23 AM | Arkin Moshe (Filed by)
UroGen Pharma (Subject)
| Form SC 13D/A | |
02/14/2024
6:07 AM | RTW INVESTMENTS, LP (Filed by)
UroGen Pharma (Subject)
| Form SC 13G | |
02/12/2024
4:47 PM | Kim Dong (Reporting)
UroGen Pharma (Issuer)
| Form 4/A | |
02/12/2024
4:43 PM | Kim Dong (Reporting)
UroGen Pharma (Issuer)
| Form 4/A | |
02/07/2024
3:15 PM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
8:15 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4/A | |
02/05/2024
8:16 PM | Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
| Form 4/A | |
02/02/2024
6:04 PM | Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:05 PM | Kim Dong (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:07 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:12 PM | Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:18 PM | BlackRock Inc. (Filed by)
UroGen Pharma (Subject)
| Form SC 13G | |
02/01/2024
9:13 AM | Schoenberg Mark (Reporting)
UroGen Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
8:53 AM | Smith Jason Drew (Reporting)
UroGen Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
3:16 PM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
7:04 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
3:30 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
UroGen Pharma (Subject)
| Form SC 13G | |
11/14/2023
3:20 PM | UroGen Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/17/2023
11:15 PM | UroGen Pharma (Filer)
| Form EFFECT | |
09/15/2023
12:39 PM | GREAT POINT PARTNERS LLC (Filed by)
UroGen Pharma (Subject)
| Form SC 13G | |
09/11/2023
3:15 PM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
3:16 PM | UroGen Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/08/2023
2:40 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
2:41 PM | Kim Dong (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
2:41 PM | Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
2:41 PM | UroGen Pharma (Issuer)
WEN LEANA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
2:41 PM | Robinson James A. Jr. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
2:42 PM | Holden Stuart (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
2:42 PM | UroGen Pharma (Issuer)
Wildman Daniel George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
2:42 PM | Cohen Fred E (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
2:43 PM | BUTITTA CYNTHIA M (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
A ‘DeFi Summer’ Projected! (Ad) Top analysts are predicting DeFi coins to see massive gains in the coming months…
During this dubbed ‘DeFi Summer…’
A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. |
09/08/2023
2:43 PM | Belldegrun Arie (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:28 PM | Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
1:06 PM | UroGen Pharma (Filer)
| Form D
Notice of Exempt Offering of Securities | |
08/10/2023
7:01 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:04 AM | UroGen Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/04/2023
7:56 AM | Monograph Capital Holdings Advisors, LLC (Filed by)
UroGen Pharma (Subject)
| Form SC 13D | |
08/01/2023
3:27 PM | UroGen Pharma (Filer)
| Form ARS | |
07/28/2023
5:05 PM | Robinson James A. Jr. (Reporting)
UroGen Pharma (Issuer)
| Form 4/A | |
07/28/2023
5:06 PM | Cohen Fred E (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/27/2023
8:57 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
7:47 AM | MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
UroGen Pharma (Subject)
| Form SC 13G/A | |
06/09/2023
2:26 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
